Home ›
Trademark Categories ›
Pharmaceuticals ›
2020 ›
CA ›
CANSEEK
Trademark search for:
CANSEEK
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2020-11-01 — Application filed
2020-11-04 — Application filed
2020-12-27 — Application filed
2021-04-05 — Assigned to examiner
2021-04-06 — Approved for pub - principal register
2021-04-21 — Notification of notice of publication e-mailed
2021-05-11 — Published for opposition
2021-05-11 — Official gazette publication confirmation e-mailed
2021-07-06 — Noa e-mailed - sou required from applicant
2021-08-11 — Attorney/dom.rep.revoked and/or appointed
2021-08-11 — Teas change of owner address received
2021-08-11 — Teas change of correspondence received
2021-08-11 — Applicant/correspondence changes (non-responsive) entered
2021-08-11 — Teas revoke/app/change addr of atty/dom rep received
2021-12-08 — Sou teas extension received
2021-12-08 — Sou extension 1 filed
2021-12-08 — Sou extension 1 granted
2021-12-10 — Notice of approval of extension request e-mailed
2022-06-07 — Attorney/dom.rep.revoked and/or appointed
2022-06-07 — Teas change of correspondence received
2022-06-07 — Teas revoke/app/change addr of atty/dom rep received
2022-07-06 — Sou extension 2 filed
2022-07-07 — Sou extension received with teas petition
2022-07-07 — Notice of revival - e-mailed
2022-07-07 — Petition to revive-granted
2022-07-07 — Teas petition to revive received
2022-08-04 — Case assigned to intent to use paralegal
2022-08-05 — Sou extension 2 granted
2022-08-06 — Notice of approval of extension request e-mailed
2023-01-06 — Sou teas extension received
2023-01-06 — Sou extension 3 filed
2023-01-06 — Sou extension 3 granted
2023-01-10 — Notice of approval of extension request e-mailed
2023-07-06 — Sou teas extension received
2023-07-06 — Sou extension 4 granted
2023-07-06 — Sou extension 4 filed
2023-07-08 — Notice of approval of extension request e-mailed
2024-01-08 — Sou teas extension received
2024-01-08 — Sou extension 5 filed
2024-01-12 — Sou extension 5 granted
2024-01-13 — Notice of approval of extension request e-mailed
2024-03-12 — Attorney/dom.rep.revoked and/or appointed
2024-03-12 — Teas change of correspondence received
2024-03-12 — Teas revoke/app/change addr of atty/dom rep received
2024-08-12 — Application abandoned
2024-08-12 — Application abandoned
2024-08-12 — Final status recorded
Owner Information
Point Biopharma Inc.
Toronto, Ontario CA
Point Biopharma Inc.
Indianapolis , IN
Correspondent
John R. Rudolph Eli Lilly and Company Lilly Corporate Center www.lilly.com Indianapolis, IN 46285
Filing Details
Filing Date:
2020-11-01
Status Date:
2024-08-12
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.